Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0506 | 0.0585 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0433 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.0506 | 0.0089 | |
Brugia malayi | FXNA | 0.0055 | 0.0433 | 0.0501 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0433 | 0.0501 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0347 | 0.8647 | 1 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0055 | 0.0433 | 0.5 |
Brugia malayi | nicalin | 0.0055 | 0.0433 | 0.0501 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0519 | 0.06 |
Leishmania major | hypothetical protein, conserved | 0.0055 | 0.0433 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0433 | 0.0501 |
Schistosoma mansoni | nicalin (M28 family) | 0.0055 | 0.0433 | 0.0501 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0433 | 0.0501 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0055 | 0.0433 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.014 | 0.2808 | 0.3247 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0433 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0433 | 0.0501 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0058 | 0.0506 | 0.0585 |
Toxoplasma gondii | peptidase, M28 family protein | 0.0055 | 0.0433 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0055 | 0.0433 | 0.5 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0347 | 0.8647 | 0.8586 |
Toxoplasma gondii | hypothetical protein | 0.0055 | 0.0433 | 0.5 |
Schistosoma mansoni | glutaminyl cyclase (M28 family) | 0.0347 | 0.8647 | 1 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0055 | 0.0433 | 0.0501 |
Brugia malayi | leucyl aminopeptidase | 0.0055 | 0.0433 | 0.0501 |
Loa Loa (eye worm) | leucyl aminopeptidase | 0.0055 | 0.0433 | 0.0501 |
Mycobacterium tuberculosis | Conserved protein | 0.0055 | 0.0433 | 0.5 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0055 | 0.0433 | 0.5 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0055 | 0.0433 | 0.5 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0055 | 0.0433 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0433 | 0.5 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0055 | 0.0433 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0395 | 1 | 1 |
Schistosoma mansoni | Fxna peptidase (M28 family) | 0.0055 | 0.0433 | 0.0501 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.014 | 0.2808 | 0.3247 |
Brugia malayi | Peptidase family M28 containing protein | 0.0347 | 0.8647 | 1 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0347 | 0.8647 | 0.8586 |
Loa Loa (eye worm) | hypothetical protein | 0.0347 | 0.8647 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0058 | 0.0519 | 0.06 |
Schistosoma mansoni | glutaminyl-peptide cyclotransferase-related | 0.0055 | 0.0433 | 0.0501 |
Leishmania major | glutaminyl cyclase, putative | 0.0055 | 0.0433 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.0519 | 0.06 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0058 | 0.0519 | 0.06 |
Brugia malayi | MH2 domain containing protein | 0.014 | 0.2808 | 0.3247 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC20 (functional) | = 8.3 uM | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay | ChEMBL. | 18950902 |
IC20 (functional) | = 12.1 uM | Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay | ChEMBL. | 18950902 |
IC50 (functional) | = 28.1 uM | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay | ChEMBL. | 18950902 |
IC50 (functional) | = 43.6 uM | Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay | ChEMBL. | 18950902 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.